Showing results (601-610 of 653) with videos related to

Sort By:
Pageof 66
Journal of Virology|November 29, 2013
Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigsSita Awasthi, John W Balliet, Jessica A Flynn, et al.
Molecular Cell|May 30, 2024
hnRNPM protects against the dsRNA-mediated interferon response by repressing LINE-associated cryptic splicingRong Zheng, Mikayla Dunlap, Georg O M Bobkov, et al.
British Journal of Haematology|September 19, 2024
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cellsM Munshi, X Liu, A Kofides, et al.
NEJM Evidence|April 30, 2025
Mepolizumab for COPD with Eosinophilic Phenotype following HospitalizationCara A Flynn, Hamish J C McAuley, Omer Elneima, et al.
Cell|March 20, 2021
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactionsRyan A Flynn, Julia A Belk, Yanyan Qi, et al.
Genome Biology|August 30, 2012
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancersAlayne L Brunner, Andrew H Beck, Badreddin Edris, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutationsThomas J Tucker, Sandeep Saggar, John T Sisko, et al.
Journal of Medicinal Chemistry|October 2, 2008
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant virusesThomas J Tucker, John T Sisko, Robert M Tynebor, et al.
Nature|December 4, 2012
Control of somatic tissue differentiation by the long non-coding RNA TINCRMarkus Kretz, Zurab Siprashvili, Ci Chu, et al.
ACS Central Science|December 5, 2017
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor CytotoxicityFrederick M Tomlin, Ulla I M Gerling-Driessen, Yi-Chang Liu, et al.
Pageof 66